SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-001994
Filing Date
2020-03-04
Accepted
2020-03-04 07:04:53
Documents
111
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 20-F rdhl-20191231x20f.htm 20-F 3988387
2 EX-1.1 rdhl-20191231ex11688a8f7.htm EX-1.1 255740
3 EX-2.3 rdhl-20191231ex235041fd1.htm EX-2.3 105217
4 EX-4.10 rdhl-20191231ex410c8e164.htm EX-4.10 228630
5 EX-4.12 rdhl-20191231ex4123bd7db.htm EX-4.12 192260
6 EX-4.13 rdhl-20191231ex413f616f4.htm EX-4.13 260168
7 EX-4.14 rdhl-20191231ex4145a83b1.htm EX-4.14 1350701
8 EX-4.15 rdhl-20191231ex4154551d4.htm EX-4.15 244911
9 EX-4.16 rdhl-20191231ex41609aa0d.htm EX-4.16 182647
10 EX-4.17 rdhl-20191231ex417eea691.htm EX-4.17 1086532
11 EX-4.18 rdhl-20191231ex4183bb469.htm EX-4.18 403240
12 EX-12.1 rdhl-20191231ex121ab0733.htm EX-12.1 16318
13 EX-12.2 rdhl-20191231ex122ff5853.htm EX-12.2 18004
14 EX-13 rdhl-20191231ex13d184ec2.htm EX-13 13773
15 EX-15.1 rdhl-20191231ex151b9fda9.htm EX-15.1 7180
16 GRAPHIC rdhl20191231ex151b9fda9001.jpg GRAPHIC 2374
17 GRAPHIC rdhl20191231ex410c8e164001.jpg GRAPHIC 3696
18 GRAPHIC rdhl20191231x20f001.jpg GRAPHIC 1713
  Complete submission text file 0001558370-20-001994.txt   15498159

Data Files

Seq Description Document Type Size
19 EX-101.INS rdhl-20191231.xml EX-101.INS 2261819
20 EX-101.SCH rdhl-20191231.xsd EX-101.SCH 85997
21 EX-101.CAL rdhl-20191231_cal.xml EX-101.CAL 55356
22 EX-101.DEF rdhl-20191231_def.xml EX-101.DEF 191601
23 EX-101.LAB rdhl-20191231_lab.xml EX-101.LAB 576894
24 EX-101.PRE rdhl-20191231_pre.xml EX-101.PRE 407521
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 20-F | Act: 34 | File No.: 001-35773 | Film No.: 20685665
SIC: 2834 Pharmaceutical Preparations